Latest Strategy News

Sunshine Metals reports significant progress in North Queensland with standout gold intersections at Sybil and a $5 million placement led by Lion Selection. Board reshuffle aligns leadership with growth strategy.

CONNEQT Health has landed a significant Phase 2b clinical trial contract in the US, advancing its footprint in cardiovascular disease research with proprietary vascular assessment technology.

Tesoro Gold has reported a significant 42% increase in its Ternera gold resource alongside a robust scoping study and a $34 million equity raise to accelerate development of its El Zorro project in Chile.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

Arovella Therapeutics has secured encouraging feedback from the US FDA on reagent testing for its CAR-iNKT cell therapy, setting the stage for an IND filing this quarter and clinical trials in early 2026.

NOVONIX has reached mutual agreement to draw down an additional US$40 million tranche of convertible debentures from Yorkville Advisors, advancing its funding strategy to support growth in battery technology.

White Cliff Minerals has confirmed sediment-hosted copper mineralisation at its Rae Copper Project in Nunavut, Canada, with diamond drilling revealing multiple copper styles and promising grades. The discovery points to a fertile system with clear pathways to higher-grade zones.

Big River Industries reports a 4.9% sales decline year-to-date but highlights stabilizing revenue and resilient margins, with a cautious outlook on residential recovery and steady commercial demand.

BetMakers Technology Group kicks off FY26 with a strong financial turnaround and strategic advances, including a promising acquisition and digital wagering expansion in Nevada.

Big River Industries faced a tough FY2025 with subdued residential demand but showed resilience through cost control and cash generation. The company declared a modest dividend and announced key board changes as it eyes recovery.

BetMakers Technology Group has reported a remarkable 361% growth in adjusted EBITDA for Q1 FY26, driven by strong revenue gains and operational efficiencies, while advancing its strategic expansion into the Las Vegas racing market.

Memphasys has signed a pivotal supply agreement with Andro Diagnostics to distribute its Felix™ sperm separation system across over 200 IVF clinics in India, marking a major step in its new global go-direct commercial strategy.